Enquiry/Quote

Explore Top Pharmaceutical Products, APIs, Formulations & Intermediates from Verified Suppliers

Budesonide Respules

Strength:
0.25 mg/2 mL, 0.5 mg/2 mL, 1 mg/2 mL

Form: Inhalation Suspension for Nebulization

Reference Brands: Pulmicort Respules®(US), Pulmicort Nebuliser Suspension, Budenofalk Nebuliser Suspension(EU)

View More Get Enquiry

Fluticasone Propionate

Strength:
0.5 mg/2 mL ampoules, 1 mg/2 mL ampoules

Form: Inhalation suspension for use with nebulizers

Reference Brands: Flixotide Nebules(EU)

View More Get Enquiry

Levosalbutamol

Strength:
0.31 mg/3 mL, 0.63 mg/3 mL, and 1.25 mg/3 mL.

Form: Inhalation Solution

Reference Brands: Xopenex®(US), Levolin Respules(India)

View More Get Enquiry

Formoterol Fumarate And Budesonide

Strength:
DPI: 100 mcg Budesonide / 6 mcg Formoterol, ; MDI: 80 mcg Budesonide / 4.5 mcg Formoterol Fumarate, 160 mcg Budesonide / 4.5 mcg Formoterol Fumarate

Form: Powder For Inhalation(DPI/MDI)

Reference Brands: Symbicort®(US); Symbicort® Turbohaler®, DuoResp® Spiromax®(EU - various strengths available)

View More Get Enquiry

Tiotropium Bromide

Strength:
1.25 mcg/ actuation & 2.5 mcg/actuation

Form: Soft Mist Inhaler

Reference Brands: Spiriva® Respimat®(Eu & US)

View More Get Enquiry

Tiotropium Bromide

Strength:
18 mcg per capsule

Form: Dry Powder for Inhalation (DPI)

Reference Brands: Spiriva® HandiHaler®(US & EU)

View More Get Enquiry

Salmeterol And Fluticasone Propionate

Strength:
DPI (fluticasone/salmeterol): 100/50 mcg, 250/50 mcg, 500/50 mcg; MDI (fluticasone/salmeterol): 45/21 mcg, 115/21 mcg, 230/21 mcg

Form: Powder For Inhalation(DPI/MDI)

Reference Brands: EU & US- DPI: Advair Diskus®, AirDuo® RespiClick® , AirDuo® Digihaler®, Seretide® DiskusAirFluSal® Forspiro; EU & US - MDI: Advair HFA® , Seretide® Evohaler, Viani®

View More Get Enquiry

Oxtriphylline (Choline Theophyllinate)

Strength:
80 mg / 5 mL

Form: Oral Syrup

Reference Brands: Generics and combos with various local brands in Asia/India

View More Get Enquiry

Oxtriphylline(Choline Theophyllinate)

Strength:
200 mg, 400 mg, and 600 mg

Form: Tablets

Reference Brands: Choledyl, Brondelate & Generics available in India/ Asia

View More Get Enquiry

Glycopyrrolate + Formoterol

Strength:
Glycopyrrolate 9 mcg + Formoterol fumarate 4.8 mcg

Form: Pressurized metered-dose inhaler (pMDI)

Reference Brands: Bevespi Aerosphere(US)

View More Get Enquiry

Glycopyrrolate + Indacaterol

Strength:
Ultibro Breezhaler: Indacaterol 85 mcg + Glycopyrronium 43 mcg

Form: Inhalation powder delivered via Neohaler device/Breezhaler device

Reference Brands: Utibron Neohaler(Dis.cntd in US-2020); Ultibro Breezhaler(EU)

View More Get Enquiry

Doxofylline Tablet

Strength:
200 mg, 400 mg

Form: Tablet

Reference Brands: Doxolin, Respiridox(India)

View More Get Enquiry

Ethofylline & Theophylline

Strength:
84.7 mg Ethofylline + 25.3 mg Theophylline

Form: Injection

Reference Brands: Deriphyllin® , Derin®

View More Get Enquiry

Isoniazid Tablet

Strength:
100 mg, 300 mg

Form: Tablet

Reference Brands: Nydrazid®(US); Rimifon® (Germany)

View More Get Enquiry

Beclomethasone Dipropionate

Strength:
40 mcg/inhalation, 80 mcg/inhalation

Form: inhaler/ spray

Reference Brands: QVAR RediHaler®(US); Clenil Modulite®(EU)

View More Get Enquiry

Protionamide

Strength:
250 mg

Form: Tablet

Reference Brands: Prothion,Prothionamide(India)

View More Get Enquiry

Terbutaline Sulfate

Strength:
Tab: 2.5 mg, 5 mg; Inj: 1 mg/ml; Inhale: 0.25 mg per inhalation

Form: Tablet, Injection & inhalation

Reference Brands: Brethine® (US) & Bricanyl®(EU)

View More Get Enquiry

Pirfenidone Tablet

Strength:
267 mg , 801 mg

Form: Tablet

Reference Brands: Esbriet(US & EU)

View More Get Enquiry

Glycopyrrolate And Indacaterol

Strength:
27.5 mcg + 15.6 mcg or 85 mcg + 43 mcg

Form: Subcutaneous injection

Reference Brands: Utibron Neohaler(US), Ultibro Breezhaler(EU)

View More Get Enquiry

Poractant Alfa

Strength:
80 mg/mL

Form: Intratracheal suspension

Reference Brands: Curosurf(Eu & US)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.